Senior insider sale
Chief Commercial Officer at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$297.5K
4.29K shares
What this filing means
MOTTIWALA AZIZ plans to sell 4.29K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $297.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0001959173-26-002429
Officer· Chief Commercial Officer
Since Oct 2020
4.29K
Shares to sell
$297.5K
Approx. market value
4.29K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/16/2026
4.29KTotal acquired4.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/16/2026 | Restricted Stock Vesting Compensation | 4.29K | — |
| Total | 4.29K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.29K
Market value
$297.5K
3/17/2026
Total
Units
4.29K
Value
$297.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/17/2026 | 4.29K | $297.5K | NASDAQ | Planned |
| Total | 4.29K | $297.5K | ||